Found: 18
Select item for more details and to access through your institution.
Utilizing Cytokines to Function-Enable Human NK Cells for the Immunotherapy of Cancer.
- Published in:
- Scientifica, 2014, p. 1, doi. 10.1155/2014/205796
- By:
- Publication type:
- Article
micro RNA management of NK-cell developmental and functional programs.
- Published in:
- European Journal of Immunology, 2014, v. 44, n. 10, p. 2862, doi. 10.1002/eji.201444798
- By:
- Publication type:
- Article
Biology and clinical impact of human natural killer cells.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Biology and clinical impact of human natural killer cells.
- Published in:
- International Journal of Hematology, 2003, v. 77, n. 2, p. 7, doi. 10.1007/BF02983234
- By:
- Publication type:
- Article
Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell Lymphoma.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2932, doi. 10.3390/cancers14122932
- By:
- Publication type:
- Article
Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10-day decitabine regimen.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 12, p. 2814, doi. 10.1002/cam4.1231
- By:
- Publication type:
- Article
CD56bright NK cells exhibit potent antitumor responses following IL-15 priming.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia.
- Published in:
- Science Translational Medicine, 2016, v. 8, n. 357, p. 1, doi. 10.1126/scitranslmed.aaf2341
- By:
- Publication type:
- Article
Bendamustine/Rituximab Plus Cytarabine/Rituximab, With or Without Acalabrutinib, for the Initial Treatment of Transplant-Eligible Mantle Cell Lymphoma Patients: Pooled Data From Two Pilot Studies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 7, p. 552, doi. 10.1016/j.clml.2023.04.003
- By:
- Publication type:
- Article
A Phase I/II Trial of Panobinostat in Combination With Lenalidomide in Patients With Relapsed or Refractory Hodgkin Lymphoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
- Published in:
- Acta Neuropathologica, 2017, v. 133, n. 1, p. 61, doi. 10.1007/s00401-016-1621-6
- By:
- Publication type:
- Article
Human Cytokine-Induced Memory-Like Natural Killer Cells.
- Published in:
- Journal of Innate Immunity, 2015, v. 7, n. 6, p. 563, doi. 10.1159/000382019
- By:
- Publication type:
- Article
Single-cell T-cell receptor repertoire profiling in dogs.
- Published in:
- Communications Biology, 2024, v. 7, n. 1, p. 1, doi. 10.1038/s42003-024-06174-w
- By:
- Publication type:
- Article
Longitudinal Body Composition Changes in Diffuse Large B-cell Lymphoma Survivors: A Retrospective Cohort Study of United States Veterans.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Interleukin-1β costimulates interferon-γ production by human natural killer cells.
- Published in:
- European Journal of Immunology, 2001, v. 31, n. 3, p. 792, doi. 10.1002/1521-4141(200103)31:3<792::AID-IMMU792>3.0.CO;2-U
- By:
- Publication type:
- Article
CD56.
- Published in:
- European Journal of Immunology, 1997, v. 27, n. 2, p. 354, doi. 10.1002/eji.1830270203
- By:
- Publication type:
- Article
Natural Killer Cell Regulation by MicroRNAs in Health and Disease.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Natural Killer Cell Regulation by MicroRNAs in Health and Disease.
- Published in:
- Journal of Biomedicine & Biotechnology, 2012, v. 2012, p. 1, doi. 10.1155/2012/632329
- By:
- Publication type:
- Article